Inamul Hasan Madar

Dr. Inamul Hasan Madar is a distinguished scientist and accomplished academician, currently serving as an Associate Professor of Onco-Proteogenomics at the Center for Integrative Omics Data Science (CIODS), Yenepoya University, Mangalore, India. With an illustrious career in translational cancer research and multi-omics integration, Dr. Madar stands at the forefront of advancing precision oncology through the convergence of molecular biology, computational science, and clinical applications. Dr. Madar earned his Ph.D. in Onco-Proteogenomics from the prestigious Korea University, where his doctoral research focused on integrating mass spectrometry–based proteomics and next-generation sequencing (NGS) platforms to identify key molecular signatures in oncology. Prior to joining Yenepoya University, he contributed to several pioneering research projects as part of the scientific team at Saveetha Dental College and Saveetha Medical University, where he played an instrumental role in establishing cross-disciplinary collaborations between clinical and molecular research units. Throughout his career, Dr. Madar has consistently demonstrated excellence in both research and mentorship. His exceptional commitment to academic and scientific development earned him the Best Research Mentor Award (2024) at SIMATS, where he was recognized among more than 2,500 faculty members for his outstanding guidance and contributions to research capacity-building. In 2025, he was further honored with the Outstanding Scientist Award in Medicine (Oncology Proteogenomics), acknowledging his pioneering work in integrating proteogenomic insights into cancer diagnostics and therapeutics. Dr. Madar’s scientific contributions are reflected in an extensive body of scholarly work, including over 100 peer-reviewed publications in high-impact journals, 42 international patents, and 22 books and book chapters. His research has significantly advanced understanding in areas such as tumor heterogeneity, biomarker discovery, and molecular pathway elucidation. His innovations in oncology research bridge experimental and computational domains, translating basic discoveries into potential clinical applications. His core expertise encompasses mass spectrometry–based proteomics, NGS-driven genomics, and computational bioinformatics. Dr. Madar has developed and optimized numerous analytical pipelines for multi-omics data processing, enabling integrative analyses that unravel complex molecular interactions within cancer systems. His current research integrates artificial intelligence (AI), machine learning (ML), and deep learning (DL) approaches to construct predictive models for personalized medicine, emphasizing precision oncology and therapeutic response prediction. An ardent advocate for education and interdisciplinary learning, Dr. Madar has mentored a wide range of scholars, including MDs, MS (Surgeons), postdoctoral fellows, Ph.D. candidates, MBBS, M.Phil., M.Tech., and M.Sc. students. His mentorship philosophy emphasizes critical thinking, innovation, and ethical scientific conduct, helping young researchers translate theoretical concepts into impactful scientific outcomes. Through his dedication to research excellence and academic leadership, Dr. Inamul Hasan Madar has established himself as a leading voice in the fields of clinical and molecular oncology, proteogenomics, and integrative omics data science. His work exemplifies the synergy between molecular insight, computational precision, and clinical relevance, driving forward the global agenda of data-driven, patient-centric cancer research. As an educator, innovator, and mentor, Dr. Madar continues to inspire the next generation of scientists while contributing to the evolving landscape of translational and precision medicine.